Concepedia

Clive Diefenbacher

CD

Statistics

Publications

8

Citations

334

H-Index

8

Active since

1989

Affiliations

Eli Lilly (United States)(Current)

Novartis (Switzerland)

Clive Diefenbacher is an author at Eli Lilly (United States) specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

1989–2005

8

Publications

8

Substituted 3-Imidazo[1,2-<i>a</i>]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino- [6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3

Thomas A. Engler, James R. Henry, Sushant Malhotra et al. · Journal of Medicinal Chemistry · 2004 · 102 citations · Full text

, , +16

Dicarboxylic Acid Dipeptide Neutral Endopeptidase Inhibitors

Gary M. Ksander, Raj D. Ghai, Reynalda deJesus et al. · Journal of Medicinal Chemistry · 1995 · 82 citations · Full text

, , +9

The development of potent and selective bisarylmaleimide GSK3 inhibitors

Thomas A. Engler, Sushant Malhotra, Timothy P. Burkholder et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 62 citations · Full text

, , +8

Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11

Stéphane De Lombaert, Lisa B. Stamford, Louis Blanchard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 37 citations

, , +5

Enkephalinase inhibitors. 1. 2,4-Dibenzylglutaric acid derivatives

Gary M. Ksander, Clive Diefenbacher, Andrew Yuan et al. · Journal of Medicinal Chemistry · 1989 · 16 citations · Full text

, , +17

1–5 of 8